Tirzepatide works through dual GIP and GLP-1 receptor activation to slow gastric emptying, enhance insulin response, and reduce appetite through gut-brain signaling
And this is why medications like Ozempic, Wegovy, and Mounjaro have also been getting a lot of attention
Retatrutide produces approximately double the heart rate increase of semaglutide
As a glucagon-like peptide-1 (GLP-1) receptor agonist, semaglutide plays a pivotal role in regulating appetite and metabolism by mimicking the natural GLP-1 hormone
Interestingly, by combining GLP-1 and GIP agonism into a single molecule, the GIP/GLP-1 coagonist has enhanced therapeutic properties to improve glucose tolerance and induce weight loss, which was demonstrated in rodents, non-human primates and humans (Finan et al., 2013)
From atherosclerotic disease to cancer, the key is early screening, aggressive prevention, and proactive intervention